and effective treatment for patients with ICCs and may Purpose: To evaluate the safety and oncologic efficacy of be particularly valuable in unresectable patients, or percutaneous thermal ablation of intrahepatic cholan- those who have already undergone hepatic surgery. giocarcinoma (ICC) and identify risk factors for local Tumor size and ablation modality were not associated tumor progression (LTP). with LTP, whereas primary tumors and superficially Materials and methods: Retrospective review of an located tumors were more likely to subsequently recur. institutional tumor ablation registry demonstrated that 20 patients (9 males, 11 females; mean age Key words: Cholangiocarcinoma—Microwave 62.5 ± 15.8 years) with 50 ICCs (mean size ablation—Radiofrequency ablation—CT 1.8 ± 1.3 cm) were treated with percutaneous radiofre- quency ablation (RFA) or microwave ablation (MWA) between 2006 and 2015. Thirty-eight of the treated ICCs Cholangiocarcinoma is the second most common pri- (76%) were metastases that developed after surgical mary liver malignancy, and intrahepatic cholangiocarci- resection of the primary tumor. Patient demographics, nomas (ICCs) account for approximately 5–10% of all procedure technical parameters, and clinical outcomes cholangiocarcinomas [1, 2]. These tumors are associated were reviewed. A Cox proportional hazards model was with high rates of morbidity and mortality because they used to
Abdominal Radiology – Springer Journals
Published: Jun 4, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud